The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 12, 1998

Filed:

Feb. 12, 1997
Applicant:
Inventors:

Patricia D Murphy, Slingerland, NY (US);

Antonette C Allen, Severn, MD (US);

Christopher P Alvares, Potomac, MD (US);

Brenda S Critz, Frederick, MD (US);

Sheri J Olson, Arlington, VA (US);

Denise B Schelter, Silver Spring, MD (US);

Bin Zeng, Rockville, MD (US);

Assignee:

OncorMed, Inc., Gaithersburg, MD (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C12Q / ; C12P / ; C07H / ; C07H / ;
U.S. Cl.
CPC ...
435-6 ; 435 912 ; 435 911 ; 435 9121 ; 536 231 ; 536 235 ; 536 243 ; 536 2433 ;
Abstract

This invention is directed to three coding sequences of the BRCA1 gene. The three coding sequences, BRCA1.sup.(omi1), BRCA1.sup.(omi2) and BRCA1.sup.(omi3) as well as their frequencies of occurrence are provided together with the protein sequences they code for. Another aspect of this invention is a method of determining the consensus sequence for any gene. Another aspect of the invention is a method of identifying an individual having an increased genetic susceptibility to breast or ovarian cancer because they have inherited a causative mutation in their BRCA1 gene. This invention is also related to a method of performing gene therapy with any of the isolated BRCA1 coding sequences.


Find Patent Forward Citations

Loading…